Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?

Diagnostic Pathology

Volumn 3, Issue 1, 2008, Pages

  Zyada, Manal M ^a   Shamaa, Ali A ^b  

^a Mansoura University   (Egypt)

^b 61519   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46249097446     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-3-26     Document Type: Article

References (74)

1. Association between ratio of matrix metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. KR Berend AP Toth JM Harrelson LJ Layfielid, J Bone Joint Surg Am 1998 80 1 11 17 9469303
2. Chondrosarcoma of bone: analysis of 108 cases and evaluation for predictors of outcome. M Rizzo MA Ghert JM Harrelson SP Scully, Clin Orthop Relat Res 2001 391 224 233 11603673
3. Tumors and tumor-like lesions of the bone. Pathology, radiology and treatment. ZF Schajowic, Berlin, Springer-Verlag 2 1994 201 256
4. The biology of human chondrosarcomas: description of the cases, grading, and biochemical analysis. HJ Mankin KP Cantley L Lippiello AL Schiller CJ Campbell, J Bone Joint Surg 1980 62 160 175 7358748
5. BW Nevile DD Damm CM Allen JE Bouquot, Oral and maxillofacial pathology W.B. Saunders Company. Phil/Lond/tronto 2003
6. Chondrosarcoma of bone: an assessment of outcome. FY Lee HJ Mankin G Fondren MC Gebhardt DS Springfield AE Rosenberg LC Jennings, J Bone Joint Surg Am 1999 81 326 38 10199270
7. Primary chondrosarcoma of long bones and limb girdles. J Bjornsson RA McLeod KK Unni DM Ilstrup DJ Pritchard, Cancer 1998 83 2105 2119 9827715
8. Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. HL Evans AG Ayala MM Romsdahl, Cancer 1977 40 818 31 890662
9. The clinical approach towards chondrosarcoma. H Gelderblom PCW Hogendoorn SD Dijkstra CS van Rijswijk, The Oncologist 2008 13 320 329 18378543
10. Clear cell chondrosarcoma of bone: Long time follow-up of 18 cases. D Donati JQ Yin M Colangeli, Arch Orthop Trauma Surg 2008 128 137 142 17522879
11. Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group. RJ Grimer G Goheger A Taminiau, Eur j Cancer 2007 43 2060 2065 17720491
12. Reliability of histopathologic and radiologic grading of cartilaginous neoplasms in long bones. Skeletal Lesions Interobserver Correlation among Expert Diagnosticians (SLICED) STUDY Group, J Bone Joint Surg Am 2007 89 2113 2123 17908885
13. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. JV Bovee AM Cleton-Jansen AH Taminiau PC Hogendoorn, Lancet Oncol 2005 6 599 607 16054571
14. Diagnosis and prognosis of chondrosarcoma of bone. LB Rozeman PCW Hogendoorn JVMG Bovée, Expert Review of Molecular Diagnostics 2002 5 461 472
15. Role of matrix metalloproteinase-7 (Matrilysin) in human cancer invasion, apoptosis, growth and angiogenesis. M Ii H Yamamoto Y Adachi Y Maruyama Y Shinomura, Exp Biol Med (Maywood) 2006 231 1 20 27 16380641
16. Matrix metalloproteinases and metastasis. DE Kleiner WG Stetler-Stevenson, Cancer chemther pharmacol 1999 43 suppl s42 s51
17. Increased incidence of matrix metalloproteinases in urine of cancer patients. MA Moses D Wiederschain KR Loughlin, Cancer Res 1998 58 1395 1399 9537238
18. Marixmetalloproteinase inhibitors and cancer: trials and tribulations. LM Coussens B Fingleton LM Matrisian, Science. 2002 295 5564 2387 2392 11923519
19. Matrix metaloproteinases and their inhibitors in tumor progression. YA Declerck H Shimada SM Taylor KE Lagley, Ann NY Acad Sci 1994 732 222 232 7978795
20. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark? JA Mengshol KS Mix CE Brinckerhoff, Arthritis Rheum 2002 46 13 20 11817584
21. Eitopathogensis of osteoarthritis in: Koopman WJ, ed. Arthritis and allied conditions. J Martel-pelletier D Laieunesse JP Pelletier, A textbook of rheumatology Baltimore: Lippincott, Williams & Wilkins 2004 2199 2226
22. Differential regulation of membrane type 1- matrix metalloproteinase activity by ERK 1/2- and p38 MAPK- modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor - β1, -induced pericellular collagenolysis. HG Munshi YI Wu S Mukhopadhyay AJ Ottaviano A Sassano, J Biol Chem 2004 279 37 39042 39050 15247230
23. The regulation of human MMP-13 by licofelone, an inhibtor of cycle-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signaling pathway. C Boileau JP Pelletier G Tardif H Fahmi S Laufer, Ann Rheym Dis 2005 64 891 898
24. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotinase -2, -9 and -13. P Nyberg P Heikkilas T Sora J Luostarinen R Heljasvaara, J Biol Chem 2003 278 25 22404 22411 12690120
25. Matrix metalloproteinases. SL Parsons SA Watson PD Brown HM Collins RJC Steele, Br J Surg 1997 84 160 166 9052425
26. Matrix metalloproteinanses in tumor invasion and metastasis. S Curran GI Murray, J Pathol 1999 189 300 308 10547590
27. Membrane type I matrix metalloproteinase digest interstitial collagens and other extracellular matrix macromolecules. E Ohuchi K Imai Y Fuji H Sato M Seiko Y Okada, J Biol Chem 1997 272 2446 2451 8999957
28. Human MTb-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors. G Velesco S Cal A Merlos-Suarez AA Ferrando S Alverez, Cancer Res 2000 60 877 882 10706098
29. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix. K Hotary E Allen A Punturieri I Tana SJ Weiss, J cell Biol 2000 149 1309 1323 10851027
30. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. JP Freije I Diez-Itza M Balbin LM Sanchez R Blasco J Tolivia C Lopez-Otin, J Biol Chem 1994 269 16766 16773 8207000
31. Cellular mechanisms for human procollagenase-3 (MMP-13) activation: evidence that MTI-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. V Knauper H Will C Lopez-Otin B Smith SJ Atkinson H Stanton RM Hembry G Murphy, J Biol Chem 1996 271 17124 17131 8663255
32. Biochemical characterization of human collagenase-3. V Knauper C Lopez-Otin B Smith G Knight G Murphy, J Biol Chem 1996 271 1544 1550 8576151
33. Degradation of cartilage aggrecan by collagenase-3 (MMP-13). AJ Fosang K Last V Knauper G Murphy PJ Neame, FEBS Lett 1996 380 17 20 8603731
34. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. V Knauper S Cowell B Smith C Lopez-Otin M O'Shea H Morris, J Biol Chem 1997 272 12 17124 17131
35. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. JA Uria M Stahle-Backdahl M Seiki A Fueyo C Lopez-Otin, Cancer Res 1997 57 4882 4888 9354453
36. Collagenase- overexpression is associated with advanced local invasion in human squameous cell carcinomas of the larynx. M Carzola L Hernandez A Nadal M Boalbin F Vizoso, J pathol 1998 186 144 150 9924429
37. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. N Johnson K Airola R Grenman AL Kariniem U Saarialho-kere VM Kahari, Am J Pathol 1997 151 499 508 9250162
38. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. N Johansson M Vaalamo S Grenman S Hietanen P Klemi U Saarialho-kere VM Kahari, Am J Pathol 1999 154 469 480 10027405
39. Differential effects of TGF-β on collagenase-3 expression by human fibroblasts. JA Uria MG Jimenez M Balbin JMP Freije C Lopez-Otin, J Biol Chem 1998 273 9769 9777 9545314
40. Absence of a correlation between the presence of a single nucleotide polymorphism in the matrix metalloproteinase 1 promoter and outcome in patients of chondrosarcoma. Y Fong CM Dutton Chass N Garamszegi FH Sim SP Scully, Clin Cancer Res 2004 10 21 7329 7334 15534109
41. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. M Stahle-Backdahl B Sandsted K Bruce A Lindahl MG Jimenez JA Vega C Topez-Otin, Lab Invest 1997 76 717 728 9166290
42. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. N Johansson U Saarialho-kere K Airola R Herva L Nissinen J Westermarck E Vuorio, Dev Dyn 1997 208 3 387 397 9056642
43. Colning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthitic cartilage. PG Mitchell HA Magna LM Reeves LL Lopresti-Morrow SA Yocum PJ Rosner KF eoghegan JE Hamber, J Clin Invest 1996 97 761 768 8609233
44. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. RC Billinghurst L Dahlberg M Ionescu A Reiner R Bourne C Rorubeck P Mitchell J Hambor O Diekmann H Tschesche, J Clin Invest 1997 99 1534 1545 9119997
45. Classification of Tumors. World Health Organization, Pathology and Genetics. Tumors of Soft Tissue and Bone. Cartilage tumors IARC press, Lyon, France, Fletcher CDM, Unni KK, Mertens F, 2002 234 257
46. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. SM Hsu L Raine H Fanger, J Histochem Cytochem 1981 29 577 580 6166661
47. HLA antigens and disease. Statistical and genetical considerations. A Svejaard C Jersild K Stauf-Nielson WF Bodmr, Tissue Antigens 1974 4 95 105 4134648
48. Increased incidence of matrix metalloproteinases in urine of cancer patients. MA Moses D Wiederschain KP Loughlin, Cancer Res 1998 58 1395 1399 9537238
49. Matrix metalloproteinase-13 activity is associated with poor prognosis in colorectal cancer. MF Leeman JA Mckay GI Murray, J Clin Pathol 2002 55 758 762 12354802
50. Immunolocation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma. RA Walker DE Wooley, Virchows Arch 1999 435 574 579 10628799
51. MMP-13 (collagenase-3) in human rheumatoid synovium. O Lindy YT Konttinen T Sorsa Y Ding S Santavirta, Arthritis Rheum 1997 40 1391 1399 9259418
52. Matrix metalloproteinase-2 and -9 involvement in canine tumors. P Loukopoulos BA Mungall RC Straw JR Jhornton WF Robinson, Vet Pathol 2003 40 382 294 12824510
53. Cytokine controlof interstitialcollagenase and collagenase-3 gene expression in human chondrocytes. PD Borden A Solymar B Swcharczuk P Lindman, J Biol Chem 1996 271 23577 23581 8798568
54. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. JA Uria M Balbin JM Lopez J Alvarez, Am J Pathol 1998 153 91 101 9665469
55. IL-1 induces collagenase-3 (MMP-13) promoter activity is stably trasfected chondrocytic cells: requirement for Rumx-2 and activation by p38 MAPK and JNK pathways. JA Mengshol MP Vincenti CE Brinckerhoff, Nucleic Acid Res 2001 21 4361 4372
56. The triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in human chondrocytes. S Elliott E Hays M Mayor M Sporn M Vincenti, Arthritis Res Ther 2003 5 R285 R291 12932292
57. Mithramycin downregulates proinflammatory cytokine-induced matrix metalloproteinase gene expression in articular chondrocytes. A Liacini J Sylvester WQ Li M Zafarullah, Arthritis Res Ther 2005 7 4 777 783
58. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. KJ Heppner LM Matrisian RA Jensen WH Rodgers, Am J Pathol 1996 149 273 282 8686751
59. Human collagenase-3 is expressed in malignant squamous epithelium of the skin. K Airola N Johansson AL Kariniemi VM Kahari UK Saarialho-kere, J Invest Dermatol 1997 109 225 231 9242512
60. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. WG Steller-Stevenson R Hewitt M Corcoran, Semin cancer Biol 1996 7 147 154 8773300
61. Articular cartilage and changes in arthritis: non-collagenous proteins and proteoglycans in the extracellular matrix of cartilage. PJ Roughly, Arthritis Res 2001 3 342 347 11714388
62. Induction of matrix metalloproteinase activation cascades based on membrane- type I matrix metalloproteinase: associated activation of gelatinase a, gelatinase b and collagenase-3. S Cowell V Knauper ML Stewart, Biochem J 1998 331 453 458 9531484
63. Biological roles of fibroblast growth factor-2. A Bikfalvi S Klein G Pintucci DB Rifkin, Endocr Rev 1997 18 26 45 9034785
64. Purification and characterization of heparin binding endothelial cell growth factors. R Lobb J Sasse R Sullivan Y Shing P D'Amore J Jacobs M Klags-brun, J Biol Chem 1986 261 1924 1928 3003088
65. Fibroblast growth factor receptors for acidic and basic fibroblast growth factor. M Jaye J Schlessinger C Dionne, Biochem Biophys Acta 1992 1135 185 189 1319744
66. Benign and malignant cartilage tumors of bone and joint-their anatomic and theoretical basis with an emphasis on radiology. Pathology and clinical biology-1. The intramedullary cartilage tumors (Review). EW Brien JM Mirra R Kerr, Skeletal Radiology 1997 26 325 353 9229417
67. Loss of heterzygosity and tumor suppressor gene mutations in chondrosarcomas. T Yamaguchi J Toguchida B Wadayama H Kanoe, Anticancer Res 1996 16 4A 2009 2015 8712735
68. Collagenase specificity in chondrosarcoma metastasis. SP Scully KR Berend WN Qi JM Harrelson, Braz J Med Biol Res 1999 32 7 885 889 10454748
69. Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumors of bone. Y Ueda Y Oda H Tsuchiya K Tomita I Nakanishi, Virchows Arch A Pathol Anat Histopathol 1990 417 4 291 297 2122578
70. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms. T Aigner S Dertinger SI Vornehm J Dudhia, Am J Path 1997 150 2133 2141 9176404
71. Collagenases and tissue inhibitor of metalloproteinases: A functional balance in tissue degradation. JJ Reynolds, Oral Dis 1996 2 70 76 8957940
72. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: A major induction of stromal MMP-13. Marc A Lafleur Angela F Drew Emma L de Sousa Tony Blick Margaret Bills Emma C Walker Elizabeth D Williams Mark Waltham Erik W Thompson, Int J Cancer. 2005 114 4 544 554 15551360
73. Pharmacological inhibition of gelatinase B induction and tumor cell invasion. JI McMillan R Weeks JW West S Bursten GC Rice DH Lovett, Int J Cancer 1996 67 523 531 8759612
74. Synthetic inhibitors of matrix metalloproteinases. PD Brown, Matrix metalloproteinases Sandieqo: Academic Press, Parks WC, Mecham RP, 1998 243 256